drugset / Trial / NCT03510611

A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers.

NCT03510611

Phase 1 Completed 24 enrolled Betta Pharmaceuticals Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this study is to evaluate the Effect of Food on the Pharmacokinetics of Ensartinib Capsules.

Timeline

Start
2018-03-12
Primary completion
2018-08-02
Completion
2018-08-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ensartinib Small molecule 225 mg